What to expect when you take Tekturna and Lotrel?

Do you take Tekturna and Lotrel? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Aug, 19, 2018

4,024 reports have been studied.


Females aged 50 to 59 :

2,064 related reports were analyzed:

Most common symptoms:

Anaemia (lack of blood)
  • 5.71% for females aged 50 (±5) who take Lotrel
Chest pain
  • 7.4% for females aged 50 (±5) who take Lotrel
Depression
  • 6.56% for females aged 50 (±5) who take Lotrel
Diarrhea
  • 7.19% for females aged 50 (±5) who take Lotrel
Dizziness
  • 7.48% for females aged 50 (±5) who take Lotrel
Dyspnea (difficult or laboured breathing)
  • 8.53% for females aged 50 (±5) who take Lotrel
  • 5.11% for females aged 50 (±5) who take Tekturna
Fatigue (feeling of tiredness)
  • 7.62% for females aged 50 (±5) who take Lotrel
Headache (pain in head)
  • 7.12% for females aged 50 (±5) who take Lotrel
  • 6.19% for females aged 50 (±5) who take Tekturna
High blood pressure
  • 11.46% for females aged 50 (±5) who take Tekturna
  • 7.76% for females aged 50 (±5) who take Lotrel
Hypoaesthesia (reduced sense of touch or sensation)
  • 5.15% for females aged 50 (±5) who take Lotrel
Injury
  • 5.43% for females aged 50 (±5) who take Lotrel
Joint pain
  • 5.85% for females aged 50 (±5) who take Lotrel
Nausea (feeling of having an urge to vomit)
  • 11.0% for females aged 50 (±5) who take Lotrel
  • 6.04% for females aged 50 (±5) who take Tekturna
Nausea and vomiting
  • 5.29% for females aged 50 (±5) who take Lotrel
Oedema peripheral (superficial swelling)
  • 6.98% for females aged 50 (±5) who take Lotrel
Pain
  • 9.31% for females aged 50 (±5) who take Lotrel
Pain in extremity
  • 6.56% for females aged 50 (±5) who take Lotrel
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  • 5.71% for females aged 50 (±5) who take Lotrel
Rashes (redness)
  • 7.74% for females aged 50 (±5) who take Tekturna
Renal impairment (severely reduced kidney function)
  • 5.42% for females aged 50 (±5) who take Tekturna
Stress and anxiety
  • 8.32% for females aged 50 (±5) who take Lotrel
Urinary tract infection
  • 6.7% for females aged 50 (±5) who take Lotrel
Weakness
  • 8.67% for females aged 50 (±5) who take Lotrel
Weight decreased
  • 5.64% for females aged 50 (±5) who take Lotrel

Most common co-existing conditions:

Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles)
  • 5.57% for females aged 50 (±5) who take Tekturna
Cardiac failure
  • 7.89% for females aged 50 (±5) who take Tekturna
Depression
  • 5.15% for females aged 50 (±5) who take Lotrel
Diabetes
  • 6.81% for females aged 50 (±5) who take Tekturna
  • 5.85% for females aged 50 (±5) who take Lotrel
High blood cholesterol
  • 7.48% for females aged 50 (±5) who take Lotrel
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  • 5.57% for females aged 50 (±5) who take Lotrel
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  • 6.77% for females aged 50 (±5) who take Lotrel
back to top

Males aged 50 to 59 :

1,960 related reports were analyzed:

Most common symptoms:

Blood creatinine increased
  • 7.45% for males aged 50 (±5) who take Tekturna
Cardiac failure
  • 5.86% for males aged 50 (±5) who take Tekturna
Chest pain
  • 5.7% for males aged 50 (±5) who take Lotrel
Concomitant disease progression (progress in accompanying disease)
  • 5.49% for males aged 50 (±5) who take Tekturna
Diarrhea
  • 5.17% for males aged 50 (±5) who take Lotrel
Dyspnea (difficult or laboured breathing)
  • 6.59% for males aged 50 (±5) who take Tekturna
Fatigue (feeling of tiredness)
  • 5.61% for males aged 50 (±5) who take Lotrel
Heart attack
  • 8.76% for males aged 50 (±5) who take Lotrel
High blood pressure
  • 8.3% for males aged 50 (±5) who take Tekturna
  • 6.57% for males aged 50 (±5) who take Lotrel
Nausea (feeling of having an urge to vomit)
  • 6.31% for males aged 50 (±5) who take Lotrel
Oedema peripheral (superficial swelling)
  • 5.37% for males aged 50 (±5) who take Tekturna
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen)
  • 6.05% for males aged 50 (±5) who take Lotrel

Most common co-existing conditions:

Cardiac failure
  • 15.02% for males aged 50 (±5) who take Tekturna
Depression
  • 5.35% for males aged 50 (±5) who take Lotrel
Diabetes
  • 10.25% for males aged 50 (±5) who take Lotrel
  • 9.28% for males aged 50 (±5) who take Tekturna
High blood cholesterol
  • 11.39% for males aged 50 (±5) who take Lotrel
Hyperlipidaemia (presence of excess lipids in the blood)
  • 6.84% for males aged 50 (±5) who take Tekturna
Pain
  • 5.08% for males aged 50 (±5) who take Lotrel
Type 2 diabetes
  • 5.49% for males aged 50 (±5) who take Tekturna
  • 5.43% for males aged 50 (±5) who take Lotrel
back to top

Related studies

Tekturna

Tekturna has active ingredients of aliskiren hemifumarate. It is often used in high blood pressure. (latest outcomes from Tekturna 4,264 users)

Lotrel

Lotrel has active ingredients of amlodipine besylate; benazepril hydrochloride. It is often used in high blood pressure. (latest outcomes from Lotrel 11,801 users)

Tekturna and Lotrel

Analysis tools (to study 499 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Tekturna, Lotrel

Recent updates

General studies
Active Support Groups
Recent Care Guides

No recent care guides.


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.